Nothoprocta perdicaria
| UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology ▲ |
|---|---|---|---|---|---|
| A0A8C6YZN9 | Noggin |
|
1 | 0 |
|
| A0A8C6ZJH3 | Potassium channel subfamily K member |
|
1 | 0 |
|
| A0A8C6YSF0 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A8C6ZM75 | Angiotensin-converting enzyme |
|
3 | 0 |
|
| A0A8C6YNW4 | Hyaluronidase |
|
1 | 0 |
|
| A0A8C6YP33 | P2X purinoceptor |
|
1 | 0 |
|
| A0A8C6ZUU5 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A8C7EHQ4 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A8C6Z8S2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A8C6YHX8 | GDNF family receptor alpha |
|
2 | 0 |
|
| A0A8C7E902 | P2X purinoceptor |
|
1 | 0 |
|
| A0A8C7ECV8 | Phosphoinositide phospholipase C |
|
1 | 0 |
|
| A0A8C6YHP6 | GDNF family receptor alpha-2 |
|
1 | 0 |
|
| A0A8C6ZWV1 | Fibroblast growth factor receptor |
|
8 | 0 |
|
| A0A8C7EE43 | Angiotensin-converting enzyme |
|
6 | 0 |
|
| A0A8C6Z857 | Rhodopsin |
|
2 | 0 |
|
| A0A8C6ZZ62 | GDNF family receptor alpha |
|
2 | 0 |
|
| P52248 | Ovomucoid (Fragment) |
|
1 | 0 |
|
| A0A8C7A6Y8 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A8C6Z245 | Rhodopsin |
|
2 | 0 |
|
| A0A8C6ZAI4 | Protein adenylyltransferase FICD |
|
1 | 0 |
|
| A0A8C6ZII5 | Cathepsin D |
|
2 | 0 |
|
| A0A8C7A454 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
| A0A8C6YQS6 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
| A0A8C6ZKA0 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025